
Acadia Pharmaceuticals Inc (ACAD)
NASDAQ
The current ACAD market cap is 3.68B. The company's latest EPS is USD 1.3531 and P/E is 16.27.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 205.83M | 241.96M | 250.4M | 259.6M | 244.32M |
Operating Income | 15.21M | 30.44M | 31.64M | 6.99M | 19.29M |
Net Income | 16.56M | 33.39M | 32.77M | 143.74M | 18.99M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 441.76M | 484.15M | 517.24M | 726.44M | 957.8M |
Operating Income | -286.59M | -170.44M | -223.6M | -73.38M | 84.28M |
Net Income | -281.58M | -167.87M | -215.98M | -61.29M | 226.45M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 855.1M | 914.1M | 976.87M | 1.19B | 1.13B |
Total Liabilities | 391.06M | 397.4M | 399.69M | 454.96M | 367.13M |
Total Equity | 464.04M | 516.7M | 577.18M | 732.79M | 765.24M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 782.62M | 700.12M | 587.81M | 748.96M | 1.19B |
Total Liabilities | 155.61M | 159.23M | 187.4M | 317.2M | 454.96M |
Total Equity | 627.01M | 540.89M | 400.41M | 431.76M | 732.79M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 29.08M | 54.09M | 117.34M | 157.72M | 20.32M |
Investing | -14.04M | -70.23M | -152.69M | -30.54M | -124.05M |
Financing | 1.04M | 4.61M | 4.88M | 6.85M | 1.84M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -136.17M | -125.66M | -114.04M | 16.7M | 157.72M |
Investing | 192.51M | -71.1M | 73.24M | 32M | -30.54M |
Financing | 81M | 18.16M | 8.2M | 25.13M | 6.85M |
Market Cap | 3.68B |
Price to Earnings Ratio | 16.27 |
Price to Sales Ratio | 3.85 |
Price to Cash Ratio | 11.53 |
Price to Book Ratio | 5.03 |
Dividend Yield | - |
Shares Outstanding | 167.36M |
Average Volume (1 week) | 1.96M |
Average Volume (1 Month) | 2.2M |
52 Week Change | 21.80% |
52 Week High | 25.23 |
52 Week Low | 13.40 |
Spread (Intraday) | 0.72 (3.2%) |
Company Name | Acadia Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.acadia-pharm.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.